Drug Profile
BX 2000
Alternative Names: BX-2000; CW-1759-50; RP 2000Latest Information Update: 28 Feb 2023
Price :
$50
*
At a glance
- Originator Cornell University
- Developer Baudax Bio
- Class Anaesthetics
- Mechanism of Action Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Anaesthesia